Nitrates in Biliary Colic

Mechanism of Action

• The sphincter of Oddi (SO) - the key gatekeeper at the choledochoduodenal junction
• The common bile duct
• The gallbladder wall (to a lesser degree)

• Papillary contraction amplitude fell from ~69 to ~37 mmHg (p < 0.005)
• Sphincter of Oddi baseline pressure fell from ~8.9 to ~2.9 mmHg (p < 0.005)
• Contraction frequency was unchanged

Clinical Uses in Biliary Colic

1. Acute Pain Relief

• Sublingual GTN acts within 1-3 minutes, providing rapid smooth muscle relaxation of the cystic duct, common bile duct, and sphincter of Oddi.
• This relieves the obstructive/spasmodic component of biliary colic pain - particularly useful when the pain is driven by ductal spasm or a temporarily impacted small stone.
• It is used as an adjunct to NSAIDs (the first-line analgesics) and antispasmodics when faster biliary decompression is needed.

2. Facilitation of Spontaneous Stone Passage

• In patients with small common bile duct (CBD) stones causing biliary colic, sublingual GTN can relax the sphincter of Oddi enough to allow spontaneous passage of the stone, potentially avoiding ERCP or endoscopic papillary dilation.
• A clinical study (Mansour et al., EC Gastroenterology 2020) demonstrated GTN's efficacy in managing small CBD stones in patients with chronic calcular cholecystitis due to sphincter of Oddi spasm - stones passed medically with GTN in a subset of patients.

3. Pre-procedure Aid for Endoscopic Stone Removal

• GTN has been used as premedication before ERCP to relax the sphincter, facilitating removal of small-to-medium CBD stones through the intact papilla without sphincterotomy.
• This is particularly valuable when sphincterotomy carries higher risk (e.g., bleeding diathesis, anticoagulation).

4. Sphincter of Oddi Dysfunction (SOD)

• In SOD (post-cholecystectomy biliary-type pain with elevated SO pressure), GTN is used - often in combination with nifedipine and/or tricyclic antidepressants - as a non-invasive medical therapy.
• About 51% of SOD patients improve with medical therapy (GTN + nifedipine + low-dose TCA) before needing sphincterotomy.
• A 2023 MDPI review on SO dysfunction classifies GTN among Level 5 evidence interventions for SOD types 1, 2, and 3 - the mechanism being direct relaxation of SO musculature.

Drug and Dose

Limitations and Side Effects

• Hypotension - the most significant concern; nitrates can cause marked systemic vasodilation and reflex tachycardia, especially in volume-depleted patients (common with vomiting in biliary colic).
• Headache and flushing - due to meningeal vessel dilation.
• Tolerance develops with prolonged/repeated use (sulfhydryl group depletion, ROS generation).
• Long-term studies specifically for biliary colic are lacking; evidence remains primarily short-term.
• GTN is not a primary analgesic - it does not replace NSAIDs or opioids for pain control, but complements them by relieving the spasmodic/obstructive component.

Position in Current Management

• Rapid biliary decompression is desired
• Small CBD stone passage is being attempted medically
• ERCP premedication is needed
• Standard analgesics are insufficient or contraindicated